Weekly: Halozyme Therapeutics (HALO: $39.02) shares post worst week in seven weeks; -93c [2.3%]

Press/Media

PeriodDec 16 2023

Media coverage

1

Media coverage

  • TitleWeekly: Halozyme Therapeutics (HALO: $39.02) shares post worst week in seven weeks; -93c [2.3%]
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date12/16/23
    PersonsMary Daly
View all 1
View less